Genesis HealthCare (GEN) Reports In-Line Q2 EPS, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mail
Get Alerts GEN Hot Sheet
Join SI Premium – FREE
Genesis HealthCare (NASDAQ: GEN) reported Q2 EPS of $0.54, in-line with the analyst estimate of $0.54. Revenue for the quarter came in at $974 million versus the consensus estimate of $970.01 million.
GUIDANCE:
Genesis HealthCare sees FY2025 EPS of $2.18-$2.23, versus the consensus of $2.21. Genesis HealthCare sees FY2025 revenue of $3.905-3.93 billion, versus the consensus of $3.913 billion.
For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- StoneX Starts SoFi Technologies (SOFI) at Buy
- Trump: understand they are looking at Ilhan Omar 'very carefully'
- Visa receives China approval to prepare domestic card clearing operations
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
